Immatics
why cells | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
43 of 75
Related slides by other companies
BioNTech
Results
May 2021
neo stim personalized targeted adoptive cell therapy addresses limitations of til cell therapy approaches | BioNTech
Evotec
Investor Presentation
July 2022
transformative based disease modelling cell therapy | Evotec
23andMe
Investor Day
January 2022
me targeting a genetically validated approach to anti cancer therapy | 23andMe
23andMe
Investor Presentation
August 2022
me targeting a genetically validated approach to anti cancer therapy | 23andMe
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights